biomarkers for immune-oncology therapies

• Germany
• Healthcare
• Pharma & Biotech
• Technology

QIAGEN receives worldwide license from The Johns Hopkins University for biomarkers for immune-oncology therapies in cancer treatment

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany,…